2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), pac...

FDA Recall #D-0228-2026 — Class II — October 31, 2025

Recall #D-0228-2026 Date: October 31, 2025 Classification: Class II Status: Ongoing

Product Description

2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16.

Reason for Recall

Defective container: cracked/broken cartridges

Recalling Firm

Novocol Pharmaceutical of Canada, Inc. — Cambridge

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

18,789 cartons- 50 cartridges /carton

Distribution

U.S.A. Nationwide

Code Information

Lot: D05337B, expires: 06-30-2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated